Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart scales could keep heart amyloidosis patients out of hospital

NCT ID NCT05098665

Recruiting now Disease control Sponsor: Richmond Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether daily weight monitoring at home can reduce hospitalizations for heart failure in people with cardiac amyloidosis, a condition where protein buildup stiffens the heart. 320 adults with ATTR cardiomyopathy will either use a connected scale that alerts doctors if fluid builds up, or receive usual care. The goal is to see if early detection of weight gain (a sign of fluid overload) can prevent serious complications and deaths.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Remote cardiac telemonitoring service (digital scales and clinical algorithm)
What this could lead to
If successful, this could provide a simple, low-cost way to keep people with cardiac amyloidosis out of the hospital and improve their quality of life.
What could go wrong
This is a relatively small trial (320 people) testing a monitoring approach, not a new drug. It may not show a clear benefit over usual care, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTR CARDIOMYOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Amyloid Neuropathies, Familial amyloidosis wild type ATTR amyloidosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC AMYLOIDOSIS

Contacts and locations

Locations

  • Richmond Research Institute

    RECRUITING

    London, London, SW17 0RE, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.